SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-289550
Filing Date
2022-11-21
Accepted
2022-11-21 08:16:01
Documents
14
Period of Report
2022-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d370439d8k.htm   iXBRL 8-K 30350
2 EX-10.1 d370439dex101.htm EX-10.1 68713
3 EX-99.1 d370439dex991.htm EX-99.1 5756
  Complete submission text file 0001193125-22-289550.txt   236739

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atnx-20221116.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20221116_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20221116_pre.xml EX-101.PRE 11262
8 EXTRACTED XBRL INSTANCE DOCUMENT d370439d8k_htm.xml XML 3338
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 221403541
SIC: 2834 Pharmaceutical Preparations